Protective effect of topical antibiotics in breast augmentation

Philip Pfeiffer; Signe Jørgensen; Thomas B Kristiansen; Anna Jørgensen; Lisbet R Hölmich

doi:10.1097/PRS.0b013e3181addc68

Protective effect of topical antibiotics in breast augmentation

Philip Pfeiffer, Signe Jørgensen, Thomas B Kristiansen, Anna Jørgensen, Lisbet R Hölmich

Department of Clinical Medicine

46 Citations (Scopus)

Abstract

BACKGROUND: Previous studies indicate that antibacterial lavage and/or use of topical antibiotics may reduce infection in breast implant surgery and perhaps also reduce occurrence of capsular contracture. A retrospective analysis was performed to evaluate this effect. METHODS: The study participants included all women (n = 436) who underwent breast augmentation during two different time periods: 2000 to 2002 (n = 218) and 2005 to 2007 (n = 218). During the first period (2000 to 2002), cephalothin (Keflin), was added to the saline/epinephrine solution, which was used to irrigate the implant pocket and filled into the outer lumen of the saline/gel implants. In the second period (2005 to 2007), only saline/epinephrine was used. All women were operated on at the same clinic and by the same surgeon. Recorded postoperative complications included occurrence of infection, seroma, and capsular contracture. RESULTS: Medical records were identified for 414 women (94.9 percent): 2000 to 2002 (n = 203) and 2005 to 2007 (n = 211); 99.8 percent of all implants were placed in the submuscular position and 99.8 percent of all incisions were periareolar. Frequency of infection in the 2005 to 2007 cohort (12.8 percent) exceeded substantially the frequency among the 2000 to 2002 cohort (6.7 percent; p = 0.044), as did the frequency of seroma (7.6 percent versus 2.9 percent, respectively; p = 0.036). There was no significant difference in development of capsular contraction between the two groups (8.1 percent versus 5.9 percent; p = 0.393). CONCLUSION: The authors' data support the use of topical antibiotics in cosmetic breast surgery, because significant increases of both infections and seroma were seen in patients not treated with topical antibiotics compared with a cohort of similar patients where topical antibiotics were used.

Original language	English
Journal	Plastic and Reconstructive Surgery
Volume	124
Issue number	2
Pages (from-to)	629-34
Number of pages	6
ISSN	0032-1052
DOIs	https://doi.org/10.1097/PRS.0b013e3181addc68
Publication status	Published - 2009

Access to Document

10.1097/PRS.0b013e3181addc68

Cite this

@article{5a5360c085b611df928f000ea68e967b,

title = "Protective effect of topical antibiotics in breast augmentation",

abstract = "BACKGROUND: Previous studies indicate that antibacterial lavage and/or use of topical antibiotics may reduce infection in breast implant surgery and perhaps also reduce occurrence of capsular contracture. A retrospective analysis was performed to evaluate this effect. METHODS: The study participants included all women (n = 436) who underwent breast augmentation during two different time periods: 2000 to 2002 (n = 218) and 2005 to 2007 (n = 218). During the first period (2000 to 2002), cephalothin (Keflin), was added to the saline/epinephrine solution, which was used to irrigate the implant pocket and filled into the outer lumen of the saline/gel implants. In the second period (2005 to 2007), only saline/epinephrine was used. All women were operated on at the same clinic and by the same surgeon. Recorded postoperative complications included occurrence of infection, seroma, and capsular contracture. RESULTS: Medical records were identified for 414 women (94.9 percent): 2000 to 2002 (n = 203) and 2005 to 2007 (n = 211); 99.8 percent of all implants were placed in the submuscular position and 99.8 percent of all incisions were periareolar. Frequency of infection in the 2005 to 2007 cohort (12.8 percent) exceeded substantially the frequency among the 2000 to 2002 cohort (6.7 percent; p = 0.044), as did the frequency of seroma (7.6 percent versus 2.9 percent, respectively; p = 0.036). There was no significant difference in development of capsular contraction between the two groups (8.1 percent versus 5.9 percent; p = 0.393). CONCLUSION: The authors' data support the use of topical antibiotics in cosmetic breast surgery, because significant increases of both infections and seroma were seen in patients not treated with topical antibiotics compared with a cohort of similar patients where topical antibiotics were used.",

author = "Philip Pfeiffer and Signe J{\o}rgensen and Kristiansen, {Thomas B} and Anna J{\o}rgensen and H{\"o}lmich, {Lisbet R}",

note = "Keywords: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Breast Implantation; Cephalothin; Contracture; Female; Humans; Irrigation; Middle Aged; Postoperative Complications; Prosthesis-Related Infections; Retrospective Studies; Seroma; Treatment Outcome; Young Adult",

year = "2009",

doi = "10.1097/PRS.0b013e3181addc68",

language = "English",

volume = "124",

pages = "629--34",

journal = "Plastic and Reconstructive Surgery",

issn = "0032-1052",

publisher = "Lippincott Williams & Wilkins",

number = "2",

}

TY - JOUR

T1 - Protective effect of topical antibiotics in breast augmentation

AU - Pfeiffer, Philip

AU - Jørgensen, Signe

AU - Kristiansen, Thomas B

AU - Jørgensen, Anna

AU - Hölmich, Lisbet R

N1 - Keywords: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Breast Implantation; Cephalothin; Contracture; Female; Humans; Irrigation; Middle Aged; Postoperative Complications; Prosthesis-Related Infections; Retrospective Studies; Seroma; Treatment Outcome; Young Adult

PY - 2009

Y1 - 2009

N2 - BACKGROUND: Previous studies indicate that antibacterial lavage and/or use of topical antibiotics may reduce infection in breast implant surgery and perhaps also reduce occurrence of capsular contracture. A retrospective analysis was performed to evaluate this effect. METHODS: The study participants included all women (n = 436) who underwent breast augmentation during two different time periods: 2000 to 2002 (n = 218) and 2005 to 2007 (n = 218). During the first period (2000 to 2002), cephalothin (Keflin), was added to the saline/epinephrine solution, which was used to irrigate the implant pocket and filled into the outer lumen of the saline/gel implants. In the second period (2005 to 2007), only saline/epinephrine was used. All women were operated on at the same clinic and by the same surgeon. Recorded postoperative complications included occurrence of infection, seroma, and capsular contracture. RESULTS: Medical records were identified for 414 women (94.9 percent): 2000 to 2002 (n = 203) and 2005 to 2007 (n = 211); 99.8 percent of all implants were placed in the submuscular position and 99.8 percent of all incisions were periareolar. Frequency of infection in the 2005 to 2007 cohort (12.8 percent) exceeded substantially the frequency among the 2000 to 2002 cohort (6.7 percent; p = 0.044), as did the frequency of seroma (7.6 percent versus 2.9 percent, respectively; p = 0.036). There was no significant difference in development of capsular contraction between the two groups (8.1 percent versus 5.9 percent; p = 0.393). CONCLUSION: The authors' data support the use of topical antibiotics in cosmetic breast surgery, because significant increases of both infections and seroma were seen in patients not treated with topical antibiotics compared with a cohort of similar patients where topical antibiotics were used.

AB - BACKGROUND: Previous studies indicate that antibacterial lavage and/or use of topical antibiotics may reduce infection in breast implant surgery and perhaps also reduce occurrence of capsular contracture. A retrospective analysis was performed to evaluate this effect. METHODS: The study participants included all women (n = 436) who underwent breast augmentation during two different time periods: 2000 to 2002 (n = 218) and 2005 to 2007 (n = 218). During the first period (2000 to 2002), cephalothin (Keflin), was added to the saline/epinephrine solution, which was used to irrigate the implant pocket and filled into the outer lumen of the saline/gel implants. In the second period (2005 to 2007), only saline/epinephrine was used. All women were operated on at the same clinic and by the same surgeon. Recorded postoperative complications included occurrence of infection, seroma, and capsular contracture. RESULTS: Medical records were identified for 414 women (94.9 percent): 2000 to 2002 (n = 203) and 2005 to 2007 (n = 211); 99.8 percent of all implants were placed in the submuscular position and 99.8 percent of all incisions were periareolar. Frequency of infection in the 2005 to 2007 cohort (12.8 percent) exceeded substantially the frequency among the 2000 to 2002 cohort (6.7 percent; p = 0.044), as did the frequency of seroma (7.6 percent versus 2.9 percent, respectively; p = 0.036). There was no significant difference in development of capsular contraction between the two groups (8.1 percent versus 5.9 percent; p = 0.393). CONCLUSION: The authors' data support the use of topical antibiotics in cosmetic breast surgery, because significant increases of both infections and seroma were seen in patients not treated with topical antibiotics compared with a cohort of similar patients where topical antibiotics were used.

U2 - 10.1097/PRS.0b013e3181addc68

DO - 10.1097/PRS.0b013e3181addc68

M3 - Journal article

C2 - 19644284

SN - 0032-1052

VL - 124

SP - 629

EP - 634

JO - Plastic and Reconstructive Surgery

JF - Plastic and Reconstructive Surgery

IS - 2

ER -

Protective effect of topical antibiotics in breast augmentation

Abstract

Access to Document

Fingerprint

Cite this